• Susan Miles, Kerry M Rogers, Paul Thomas, Barry Soans, John Attia, Christian Abel, Elizabeth Holt, Catherine A D'Este, and Michael J Hensley.
• Department of General Medicine, Calvary Mater Newcastle, Newcastle, NSW, Australia. susan.miles@mater.health.nsw.gov.au
• Chest. 2009 Dec 1;136(6):1546-53.

BackgroundThis study compared single-photon emission CT (SPECT) ventilation/perfusion (V/Q) scintigraphy with multislice CT pulmonary angiography (CTPA).MethodsIn a prospective, observational study, 100 patients who were >or= 50 years of age were recruited. Seventy-nine patients underwent both diagnostic 16-detector CTPA, and planar and SPECT V/Q scintigraphy. The agreement between the CTPA and the SPECT V/Q scintigraphy for the diagnosis of pulmonary embolism (PE) was calculated. The sensitivity and specificity of blinded SPECT scintigraphy reporting was calculated against a reference diagnosis made by a panel of respiratory physicians that was provided with CTPA and planar V/Q scintigraphy reports, clinical information, and 3-month follow-up data.ResultsThe observed percentage of agreement between SPECT V/Q scintigraphy and CTPA data for the diagnosis of PE was 95%. When calculated against the respiratory physicians' reference diagnosis, SPECT V/Q scintigraphy had a sensitivity of 83% and a specificity of 98%.ConclusionsThis study indicates that SPECT V/Q scintigraphy is a viable alternative to CTPA for the diagnosis of PE and has potential advantages in that it was feasible in more patients and had fewer contraindications; lower radiation dose; and, arguably, fewer nondiagnostic findings than CTPA.Trial RegistrationAustralian New Zealand Clinical Trials Registry Registration Number: ACTRN12609000089235.

24 keywords...

hide…